These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29782281)

  • 1. [Effect of chronic kidney disease on the formation of diastolic heart dysfunction in heart failure patients with preserved ejection fraction].
    Kuzmin OB; Zezha VV; Belyanin VV; Buchneva NV
    Kardiologiia; 2018 SApr; (S4):37-45. PubMed ID: 29782281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Ter Maaten JM; Damman K; Verhaar MC; Paulus WJ; Duncker DJ; Cheng C; van Heerebeek L; Hillege HL; Lam CS; Navis G; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):588-98. PubMed ID: 26861140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.
    Penicka M; Bartunek J; Trakalova H; Hrabakova H; Maruskova M; Karasek J; Kocka V
    J Am Coll Cardiol; 2010 Apr; 55(16):1701-10. PubMed ID: 20394874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with preserved ejection fraction: refocusing on diastole.
    Abbate A; Arena R; Abouzaki N; Van Tassell BW; Canada J; Shah K; Biondi-Zoccai G; Voelkel NF
    Int J Cardiol; 2015 Jan; 179():430-40. PubMed ID: 25465302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart failure with preserved ejection fraction (HFPEF). Impact of change in the paradigm of isolated diastolic dysfunction].
    Magaña-Serrano JA; Rosas-Peralta M; Candanosa-Arias C; Valencia-Sánchez S; Garrido-Garduño M; Arriaga-Nava R; Calderón-Abbo MC
    Gac Med Mex; 2015; 151(5):635-47. PubMed ID: 26526478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart failure with preserved left ventricular ejection fraction: epidemiology, patient «portrait», clinic and diagnostics].
    Gavryushina SV; Ageev FT
    Kardiologiia; 2018 SApr; (S4):55-64. PubMed ID: 29782283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEF.
    Campbell KS; Sorrell VL
    J Appl Physiol (1985); 2015 Nov; 119(10):1228-32. PubMed ID: 25911687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction.
    Karagodin I; Aba-Omer O; Sparapani R; Strande JL
    BMC Cardiovasc Disord; 2017 Feb; 17(1):62. PubMed ID: 28196483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction.
    Ovchinnikov AG; Gvozdeva AD; Blankova ZN; Borisov AA; Ageev FT
    Kardiologiia; 2020 Dec; 60(11):1352. PubMed ID: 33487158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ
    Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction.
    Kashioulis P; Lundgren J; Shubbar E; Nguy L; Saeed A; Guron CW; Guron G
    Kidney Blood Press Res; 2018; 43(4):1053-1064. PubMed ID: 29969785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.